Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
1.545
-0.005 (-0.32%)
At close: Jul 30, 2025, 4:00 PM
1.550
+0.005 (0.32%)
After-hours: Jul 30, 2025, 4:10 PM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $437.68 million as of July 30, 2025. Its market cap has decreased by -45.93% in one year.
Market Cap
437.68M
Enterprise Value
78.83M
1-Year Change
-45.93%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $437.68M, a decrease of -76.45%. That is a compound annual growth rate of -30.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 439.10M | -38.12% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.47B |
| Johnson & Johnson | 400.31B |
| AbbVie | 333.00B |
| Novo Nordisk | 311.87B |
| UnitedHealth Group | 255.92B |
| Novartis AG | 225.40B |
| AstraZeneca | 224.29B |
| Abbott Laboratories | 219.83B |